No one has carried their partner to more world championship wins than this Finnish man. Meet one of this year’s CNN Heroes who offers more than a roof over the heads of people experiencing ...

If you have at least $2,500 in savings, you could earn a competitive APY with the Ivy Bank High-Yield Savings account. Why We Like It Balances over $2,500 (and below $1 million) earn 3.85% APY. Plus, ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Caitlin Giddings and Wirecutter Staff Learning is at the center of a ...

In the 1920s, there was some controversy about whether or not tartrazine had negative effects on the health of children. Some people claimed it caused hyperactivity. But it wasn't until 1973 when ...

Cybersecurity researchers have discovered vulnerable code in legacy Python packages that could potentially pave the way for a supply chain compromise on the Python Package Index (PyPI) via a domain ...

"Penny has five children" is a riddle about a lady and her penchant for giving her kids some rather unusual names. You know the first four, but can you guess the fifth? When you first encounter the ...

Burmese pythons, an invasive species in the Everglades, are being hunted and their skins used for luxury goods. Hunters like Zach Hoffman and Amy Siewe detail the process of skinning and preparing ...

On June 11, 2025, the Python core team released Python 3.13.5, the fifth maintenance update to the 3.13 line. This release is not about flashy new language features, instead, it addresses some ...

John Wick 5 was officially confirmed in April 2025, but if you ask Chad Stahelski, it's not as guaranteed as you think. "The studio would very much will it into existence, I'm sure, at some point.

If you’ve been keeping up with autonomous vehicle news—or just spending a bit of time in our Cars category—you’ve probably seen people throw around terms like “Level 2 autonomy” or “Level 4 ...

In the years after the 2020 COVID-19 pandemic, it is clear that mRNA as a modality for vaccines and therapeutics is here to stay based on the number of mRNA programs currently in clinical development.